Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Careers and Recruitment
  • Published:

Paring down the company: the effect of consolidation in the European biotech sector

Nature Biotechnology volume 21, pages 829–830 (2003)Cite this article

The current economic downturn has led biotechs to alter their business models and shape new roles for management and investors.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Author information

Authors and Affiliations

  1. The author is at Korn/Ferry International, 123 Buckingham Palace Road, London, SW1W 9DZ, UK

    Peter Bassett

Authors
  1. Peter Bassett
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bassett, P. Paring down the company: the effect of consolidation in the European biotech sector. Nat Biotechnol 21, 829–830 (2003). https://doi.org/10.1038/nbt0703-831

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0703-831

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing